164 related articles for article (PubMed ID: 20726906)
1. Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy.
Lambert JS; Else LJ; Jackson V; Breiden J; Gibbons S; Dickinson L; Back DJ; Brennan M; Connor EO; Boyle N; Fleming C; Coulter-Smith S; Khoo SH
HIV Med; 2011 Mar; 12(3):166-73. PubMed ID: 20726906
[TBL] [Abstract][Full Text] [Related]
2. Reduced lopinavir exposure during pregnancy.
Stek AM; Mirochnick M; Capparelli E; Best BM; Hu C; Burchett SK; Elgie C; Holland DT; Smith E; Tuomala R; Cotter A; Read JS
AIDS; 2006 Oct; 20(15):1931-9. PubMed ID: 16988514
[TBL] [Abstract][Full Text] [Related]
3. Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine.
Manavi K; McDonald A; Al-Sharqui A
AIDS; 2007 Mar; 21(5):643-5. PubMed ID: 17314527
[TBL] [Abstract][Full Text] [Related]
4. Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration.
Rosso R; Di Biagio A; Dentone C; Gattinara GC; Martino AM; Viganò A; Merlo M; Giaquinto C; Rampon O; Bassetti M; Gatti G; Viscoli C
J Antimicrob Chemother; 2006 Jun; 57(6):1168-71. PubMed ID: 16606636
[TBL] [Abstract][Full Text] [Related]
5. Steady-state lopinavir levels in third trimester of pregnancy.
Lyons F; Lechelt M; De Ruiter A
AIDS; 2007 May; 21(8):1053-4. PubMed ID: 17457104
[TBL] [Abstract][Full Text] [Related]
6. Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
Baroncelli S; Villani P; Floridia M; Pirillo MF; Galluzzo CM; Cusato M; Amici R; Pinnetti C; Sabbatini F; Molinari A; Tamburrini E; Regazzi M
Ther Drug Monit; 2008 Oct; 30(5):604-10. PubMed ID: 18728627
[TBL] [Abstract][Full Text] [Related]
7. Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.
Calza L; Manfredi R; Trapani F; Salvadori C; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
Scand J Infect Dis; 2012 May; 44(5):381-7. PubMed ID: 22263609
[TBL] [Abstract][Full Text] [Related]
8. Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.
Ramautarsing RA; van der Lugt J; Gorowara M; Kerr SJ; Burger D; Ruxrungtham K; Phanuphak P; Chaithongwongwatthana S; Avihingsanon A; Phanuphak N
AIDS; 2011 Jun; 25(10):1299-303. PubMed ID: 21516029
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
[TBL] [Abstract][Full Text] [Related]
10. Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection.
Estrela RC; Ribeiro FS; Seixas BV; Suarez-Kurtz G
Rapid Commun Mass Spectrom; 2008; 22(5):657-64. PubMed ID: 18257112
[TBL] [Abstract][Full Text] [Related]
11. Changes in body fat composition after 1 year of salvage therapy with lopinavir/ritonavir-containing regimens and its relationship with lopinavir plasma concentrations.
Gutiérrez F; Padilla S; Masiá M; Navarro A; Gallego J; Hernández I; Ramos JM; Martin-Hidalgo A
Antivir Ther; 2004 Feb; 9(1):105-13. PubMed ID: 15040542
[TBL] [Abstract][Full Text] [Related]
12. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.
Else LJ; Jackson V; Brennan M; Back DJ; Khoo SH; Coulter-Smith S; Lambert JS
HIV Med; 2014 Nov; 15(10):604-10. PubMed ID: 24825070
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
Boulanger C; Hollender E; Farrell K; Stambaugh JJ; Maasen D; Ashkin D; Symes S; Espinoza LA; Rivero RO; Graham JJ; Peloquin CA
Clin Infect Dis; 2009 Nov; 49(9):1305-11. PubMed ID: 19807276
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.
van der Lugt J; Lange J; Avihingsanon A; Ananworanich J; Sealoo S; Burger D; Gorowara M; Phanuphak P; Ruxrungtham K
Antivir Ther; 2009; 14(7):1001-4. PubMed ID: 19918104
[TBL] [Abstract][Full Text] [Related]
16. The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Maillard A; Chapplain JM; Tribut O; Bentué-Ferrer D; Tattevin P; Arvieux C; Michelet C; Ruffault A
J Clin Virol; 2007 Feb; 38(2):131-8. PubMed ID: 17208042
[TBL] [Abstract][Full Text] [Related]
17. Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir.
Rathbun CR; Liedtke MD; Blevins SM; Harrison D; Lockhart SM; Salvaggio M; Acosta EP
HIV Clin Trials; 2009; 10(5):328-36. PubMed ID: 19906626
[TBL] [Abstract][Full Text] [Related]
18. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass.
Michalik DE; Jackson-Alvarez JT; Flores R; Tolentino-Baldridge C; Batra JS
J Int Assoc Provid AIDS Care; 2015; 14(2):116-9. PubMed ID: 25361558
[TBL] [Abstract][Full Text] [Related]
19. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1.
Falkensammer B; Fasser W; Scherer K; Zemann A; Parson W; Ulmer H; Dierich MP; Stoiber H
Int J Immunopathol Pharmacol; 2005; 18(1):145-54. PubMed ID: 15698519
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.
Crommentuyn KM; Kappelhoff BS; Mulder JW; Mairuhu AT; van Gorp EC; Meenhorst PL; Huitema AD; Beijnen JH
Br J Clin Pharmacol; 2005 Oct; 60(4):378-89. PubMed ID: 16187970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
